معرفی
Dr. Fei Deng is a Research Fellow at the University of New South Wales (UNSW), affiliated with the Graduate School of Biomedical Engineering. He holds prestigious fellowships including the NHMRC EL1 Fellowship and NSW Cancer Institute ECR Fellowship. His research focuses on CRISPR-based biosensing, point-of-care diagnostics, and in vivo biosensing devices, with over 45 journal articles and $12M in grants secured. Key contributions include advancements in CRISPR/Cas biosensors, liquid-metal-driven nanomaterials, and photodynamic therapy for cancer treatment. Awards include the Royal Society of NSW Early Career Award and ECAN ECR Award.
Education: PhD in Biomedical Engineering from UNSW (Australia). Research interests span biosensing technologies, CRISPR applications, and diagnostic innovations. Recent work emphasizes ultrasensitive detection systems, with notable publications in Nature Communications, ACS Nano, and Biosensors and Bioelectronics. He has co-founded Casbio Pty Ltd and advises Avicena Systems Limited.
